ERAS
Price
$16.23
Change
-$0.03 (-0.18%)
Updated
Sep 4, 11:08 AM (EDT)
Capitalization
5.69B
68 days until earnings call
Intraday BUY SELL Signals
MLTX
Price
$15.19
Change
+$0.13 (+0.86%)
Updated
Sep 3 closing price
Capitalization
1.29B
74 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ERAS vs MLTX

ERAS vs MLTX Comparison Chart in %
View a ticker or compare two or three
VS
ERAS vs. MLTX commentary
Sep 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ERAS is a StrongBuy and MLTX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2026
Stock price -- (ERAS: $16.26 vs. MLTX: $15.19)
Brand notoriety: ERAS and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ERAS: 97% vs. MLTX: 66%
Market capitalization -- ERAS: $5.69B vs. MLTX: $1.29B
ERAS [@Biotechnology] is valued at $5.69B. MLTX’s [@Biotechnology] market capitalization is $1.29B. The market cap for tickers in the [@Biotechnology] industry ranges from $141.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ERAS’s FA Score shows that 0 FA rating(s) are green whileMLTX’s FA Score has 1 green FA rating(s).

  • ERAS’s FA Score: 0 green, 5 red.
  • MLTX’s FA Score: 1 green, 4 red.
According to our system of comparison, ERAS is a better buy in the long-term than MLTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ERAS’s TA Score shows that 2 TA indicator(s) are bullish while MLTX’s TA Score has 4 bullish TA indicator(s).

  • ERAS’s TA Score: 2 bullish, 7 bearish.
  • MLTX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than ERAS.

Price Growth

ERAS (@Biotechnology) experienced а -16.57% price change this week, while MLTX (@Biotechnology) price change was -2.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.51%. For the same industry, the average monthly price growth was +6.00%, and the average quarterly price growth was +2377.30%.

Reported Earning Dates

ERAS is expected to report earnings on Nov 11, 2026.

MLTX is expected to report earnings on Nov 17, 2026.

Industries' Descriptions

@Biotechnology (+0.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ERAS($5.69B) has a higher market cap than MLTX($1.29B). ERAS YTD gains are higher at: 337.097 vs. MLTX (15.250). ERAS has higher annual earnings (EBITDA): -130.68M vs. MLTX (-245.81M). MLTX has more cash in the bank: 358M vs. ERAS (244M). ERAS has less debt than MLTX: ERAS (46M) vs MLTX (101M). ERAS (0) and MLTX (0) have equivalent revenues.
ERASMLTXERAS / MLTX
Capitalization5.69B1.29B440%
EBITDA-130.68M-245.81M53%
Gain YTD337.09715.2502,210%
P/E RatioN/AN/A-
Revenue00-
Total Cash244M358M68%
Total Debt46M101M46%
FUNDAMENTALS RATINGS
MLTX: Fundamental Ratings
MLTX
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
93
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
82
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
16

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ERASMLTX
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
70%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
70%
Advances
ODDS (%)
Bullish Trend 9 days ago
83%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 8 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
ERAS
Daily Signal:
Gain/Loss:
MLTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TOVYX23.900.28
+1.19%
American Beacon IMC Int Small Cap Y
FFAFX88.610.98
+1.12%
American Funds Growth Fd of Amer 529F--3
PZFVX23.06N/A
N/A
JHancock Classic Value A
RPBAX30.36N/A
N/A
T. Rowe Price Balanced
PHLQX53.52N/A
N/A
PGIM Jennison Health Sciences R6